DEBRISOQUINE 4-MONOOXYGENASE AND BUFURALOL 1'-MONOOXYGENASE ACTIVITIES IN BOVINE AND RABBIT-TISSUES

被引:21
作者
MATSUO, Y
IWAHASHI, K
ICHIKAWA, Y
机构
[1] Department of Biochemistry, Kagawa Medical School, Kita-gun, Kagawa, 761-07, Miki-cho
关键词
D O I
10.1016/0006-2952(92)90633-T
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The tissue distributions of debrisoquine 4-monooxygenase and bufuralol 1'-monooxygenase activities in microsomes from bovine and rabbit tissues were analysed. Debrisoquine 4-monooxygenase and bufuralol 1'-monooxygenase activities were found in liver, and at low levels in cerebral cortex, kidney cortex, lung, small intestine and spleen. Other tissues, such as kidney medulla, adrenocortex, adrenomedulla, blood vessels, thyroid gland, heart, ovary, uterus and testis, showed low levels of bufuralol 1'-monooxygenase activity but no detectable debrisoquine 4-monooxygenase activity. The bufuralol/debrisoquine monooxygenase activity ratios were higher in kidney and lung, and lower in cerebral cortex and spleen than in liver. Both monooxygenase activities in several bovine tissues including liver were inhibited strongly by phenylisocyanide (0.1 mM) and quinidine (0.5 mM), moderately by metyrapone (1 mM), and not at all by KCN (1 mM). NaN3 (5 mM) and sodium cholate (0.5% w/v) inhibited debrisoquine 4-monooxygenase activity strongly and moderately, but bufuralol 1'-monooxygenase activity moderately and strongly, respectively. No effect of a hydroxyl radical scavenger or of superoxide dismutase on either monooxygenase activity was observed. It was concluded from these results, as well as the NADPH dependency of the reactions, that the two monooxygenase reactions observed in these tissues were catalysed by cytochrome P450s.
引用
收藏
页码:1911 / 1919
页数:9
相关论文
共 46 条
[1]  
ALVARES AP, 1977, J BIOL CHEM, V252, P6373
[2]   GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES [J].
BOOBIS, AR ;
MURRAY, S ;
HAMPDEN, CE ;
DAVIES, DS .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :65-71
[3]   METABOLISM OF BENZO[A]PYRENE BY GUINEA-PIG ADRENAL AND HEPATIC MICROSOMES [J].
COLBY, HD ;
JOHNSON, PB ;
POPE, MR ;
ZULKOSKI, JS .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (05) :639-646
[4]  
DAO TL, 1964, P SOC EXP BIOL MED, V116, P1048
[5]   CYTOCHROME-P-450 DEPENDENT MONOOXYGENASES IN NEURONAL AND GLIAL-CELLS - INDUCIBILITY AND SPECIFICITY [J].
DHAWAN, A ;
PARMAR, D ;
DAS, M ;
SETH, PK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (02) :441-447
[6]  
DISTLERATH LM, 1985, J BIOL CHEM, V260, P6057
[7]   MPTP, THE NEUROTOXIN INDUCING PARKINSONS-DISEASE, IS A POTENT COMPETITIVE INHIBITOR OF HUMAN AND RAT CYTOCHROME-P450 ISOZYMES (P450BUFI, P450DB1) CATALYZING DEBRISOQUINE 4-HYDROXYLATION [J].
FONNEPFISTER, R ;
BARGETZI, MJ ;
MEYER, UA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (03) :1144-1150
[8]   XENOBIOTIC AND ENDOBIOTIC INHIBITORS OF CYTOCHROME-P-450DBL FUNCTION, THE TARGET OF THE DEBRISOQUINE SPARTEINE TYPE POLYMORPHISM [J].
FONNEPFISTER, R ;
MEYER, UA .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (20) :3829-3835
[9]   CHARACTERIZATION OF CDNAS, MESSENGER-RNAS, AND PROTEINS RELATED TO HUMAN-LIVER MICROSOMAL CYTOCHROME-P-450 (S)-MEPHENYTOIN 4'-HYDROXYLASE [J].
GED, C ;
UMBENHAUER, DR ;
BELLEW, TM ;
BORK, RW ;
SRIVASTAVA, PK ;
SHINRIKI, N ;
LLOYD, RS ;
GUENGERICH, FP .
BIOCHEMISTRY, 1988, 27 (18) :6929-6940
[10]   DEBRISOQUINE 4-HYDROXYLASE - CHARACTERIZATION OF A NEW P450 GENE SUBFAMILY, REGULATION, CHROMOSOMAL MAPPING, AND MOLECULAR ANALYSIS OF THE DA RAT POLYMORPHISM [J].
GONZALEZ, FJ ;
MATSUNAGA, T ;
NAGATA, K ;
MEYER, UA ;
NEBERT, DW ;
PASTEWKA, J ;
KOZAK, CA ;
GILLETTE, J ;
GELBOIN, HV ;
HARDWICK, JP .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1987, 6 (02) :149-161